Saol Therapeutics: Saol Therapeutics announces positive results from the SL1002 RAISE Limb Spasticity Trial
Saol Therapeutics, a privately held, clinical─stage pharmaceutical company, announced positive topline results from its SL─1002 RAISE Limb Spasticity Trial (NCT05311215). The data were recently presented
Read full article »
Saol Therapeutics is a Georgia-based pharmaceutical company that provides therapies for CNS disorders such as pain management, spasticity, and orphan diseases.
Read more